NEW YORK (GenomeWeb) – Becton Dickinson said today that its fiscal second quarter revenues slipped almost 1 percent year over year. 

For the three months ended March 31, the Franklin Lakes, New Jersey-based company posted revenues of $2.05 billion compared to $2.07 billion in the year-ago quarter. It matched the analysts' average estimate. 

On a currency-neutral basis, revenues in Q2 2015 were up 5 percent year over year, the company said. 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Consulting company McKinsey says diagnostics companies will have to combine genomic data analysis, electronic medical records, effective reimbursement strategies, and regulatory compliance in order to win.

A new report has found that researchers in Africa are still heavily dependent on funding from organizations in the US, Europe, and China, Nature News says.

An article in The Atlantic argues that the progress being made in science isn't keeping pace with the money and time being spent on research.

In Science this week: a CRISPR screen identifies sideroflexin 1 as a requisite component of one-carbon metabolism, and more.